Can Wyeth win back the 40 million Premarin and Prempro users it’s lost since 2002–along with $1 billion a year in profits–with a new menopause drug? Or will the once-bitten women who have filed more than 5,000 law suits claiming the hormones gave them cancer feel fooled twice? Pristiq, a serotonin/norepinephrine reuptake inhibitor (SNRI), is … Continue reading Can Hormone Maker Wyeth Fool American Women Twice?